Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VKTX | VIKING THERAPEUTICS INC | $3.34B | $28.75 | $104.00 | 261.74% | Strong Buy | 4 | N/A | N/A | -34.82% | -28.73% | |||
| EQT | EQT CORP | $32.49B | $51.94 | $71.08 | 36.84% | Strong Buy | 13 | -0.57% | 0.00% | 13.12% | 7.90% | |||
| BNTX | BIONTECH SE | $21.73B | $90.54 | $128.82 | 42.28% | Strong Buy | 11 | -6.97% | N/A | -4.27% | -3.79% | |||
| SLDB | SOLID BIOSCIENCES INC | $702.93M | $7.14 | $18.71 | 162.10% | Strong Buy | 7 | N/A | N/A | -0.04% | -0.04% | |||
| PCVX | VAXCYTE INC | $6.85B | $47.46 | $105.00 | 121.24% | Strong Buy | 3 | N/A | N/A | -9.72% | -8.70% | |||
| CGEM | CULLINAN THERAPEUTICS INC | $841.98M | $13.70 | $33.60 | 145.26% | Strong Buy | 5 | N/A | N/A | -47.25% | -42.93% | |||
| HIVE | HIVE DIGITAL TECHNOLOGIES LTD | $997.52M | $3.73 | $6.68 | 79.17% | Strong Buy | 6 | N/A | N/A | N/A | N/A | |||
| CATX | PERSPECTIVE THERAPEUTICS INC | $336.44M | $2.95 | $12.71 | 330.98% | Strong Buy | 7 | -10.14% | N/A | -34.82% | -29.45% | |||
| ODTX | ODYSSEY THERAPEUTICS INC | N/A | $16.90 | $32.00 | 89.35% | Strong Buy | 3 | -100.00% | N/A | N/A | -67.49% | |||
| KLRA | KAILERA THERAPEUTICS INC | $2.45B | $18.89 | $38.00 | 101.16% | Strong Buy | 3 | N/A | N/A | N/A | -77.56% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.